Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis

Clinical trial NCT06329492 · COMPLETED

Trial details

NCT number: NCT06329492
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Osteoarthritis OA Knee Osteoarthritis

Start date: 2024-01-09
Primary completion: 2026-01-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.